Pfizer’s Paxlovid Antiviral Drug Does Not Reduce Risk Of Long Covid: Study
New York: US pharma giant Pfizer's antiviral drug Paxlovid (Nirmatrelvir-ritonavir) does not reduce the risk of developing long Covid for ...
New York: US pharma giant Pfizer's antiviral drug Paxlovid (Nirmatrelvir-ritonavir) does not reduce the risk of developing long Covid for ...
Washington: The US Food and Drug Administration (FDA) has approved newly formulated Covid vaccines from Pfizer and Moderna that are ...
New York: A former Pfizer statistician and his accomplice, both hailing from India, have been charged with insider trading by the ...
New York: The new Covid shot that specifically targets Omicron variant elicits a strong immune response against the strain, widely ...
Doha: People with prior-variant infection were moderately protected from Omicron even after a year, but vaccine-induced immunity against new infection ...
Davos: Pfizer has announced it is to supply all its current and future patent-protected medicines and vaccines on a not-for-profit ...
Washington: Pfizer and its German partner BioNTech have said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 ...
New York: Pfizer on Monday announced that its third 'booster' dose was 80.3 per cent effective in preventing illness during ...
Geneva: The World Health Organisation (IANS) on Friday made a strong recommendation for Pfizer's antiviral for mild and moderate Covid-19 ...
Toronto: Regular use of viagra, used to treat erectile dysfunction, can harm your vision leaving you blind, a study has ...